Navigation Links
ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
Date:3/19/2009

Michael Bruns brings extensive experience in enterprise technology to rapidly expanding Chicago-based clinical software company; will lead company's global sales and services organization as well as manage the company's financial department.

Chicago, IL (PRWEB) March 19, 2009 -- ClearTrial (www.cleartrial.com), a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that Michael Bruns, formerly Director of the Technology Investment Banking Group at Robert W. Baird, has joined the company as Chief Operating Officer. A 17-year veteran in enterprise software and information technology markets, Bruns brings extensive experience in corporate strategy, operations, and business development to ClearTrial.

As Chief Operating Officer, Bruns will be responsible for the company's global operations and will help further develop and implement the company's growth strategy. He will oversee finance, operations, and the expansion of ClearTrial's global sales, services, and engineering organizations.

"Michael Bruns has a consistent track record of accelerating growth in enterprise software companies," noted ClearTrial CEO Mike Soenen. "His experience and skills will help drive ClearTrial's revenue growth and further cement our market leadership as we assist life sciences companies in bringing new, quality treatments to market faster, at a lower cost and with fewer resources - a critical advantage in today's market."

Prior to joining ClearTrial, Bruns founded and directed the Technology Investment Banking group at Robert W. Baird & Co., a global investment banking firm. He led the group's business development efforts and advised executive management teams and boards of directors of public and private company clients on corporate strategy, acquisition strategy, and corporate finance alternatives. Previously, Bruns was Vice President of Mergers & Acquisitions for Broadview International, LLC (now Jefferies Broadview), where he conducted strategic positioning and transaction development for enterprise software and communications technology clients.

Bruns has extensive software development and systems integration experience, having been a principal at Waterstone Consulting, LLC - a provider of complex pricing and contract management software solutions to Fortune 2000 life sciences, manufacturing, and distribution companies - and a senior consultant with Accenture. He holds a BBA in Finance from the University of Michigan, and an MBA from Harvard Business School.

"ClearTrial has all the elements in place to continue to rapidly expand market share," observed Bruns. "Our award-winning software solution brings real business value to a well-established and growing customer base, and we have a great team in place as the foundation for future growth. I'm looking forward to helping ClearTrial continue to expand our leadership in the clinical software market."

About ClearTrial®
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial's award-winning software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2247864.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
2. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
3. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
4. VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer
5. Frost & Sullivan Names Naviscan a Leader in the Future of Molecular Breast Imaging
6. The Biggest Names in the Field of Personalized Medicine to Speak at Arrowhead's Upcoming 2009 Personalized Medicine Conference
7. Neogen Names New Senior Science Officer; Added to S&P Index
8. Nexsun Corp Names Industry Executive David Pyrce as Chief Executive Officer
9. NeuroFocus Names John Polich, World-Renowned Scientist in Brain Function and Cognition, to Head Global NeuroLab Operations
10. Cequent Names Ted Hibben Chief Business Officer
11. Clarus Ventures Names Two New Partners
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer 
(Date:2/5/2016)... 5, 2016 On Thursday, February 11, ... for community, health and disaster services, and the ... to enhance care coordination and service delivery for the ... need and to better connect service providers to the ... San Diego has handled more than ...
(Date:2/4/2016)... ... February 04, 2016 , ... Morf ... today announced an interactive FDA compliance training course, Writing Effective ... Professional Society) accredited interactive course on Morf Playbook—now conveniently available on smartphones and ...
(Date:2/4/2016)... ... 2016 , ... Shimadzu Scientific Instruments will showcase several new ... poster sessions, and present on the analysis of mycotoxins and medical cannabis at ... 10 at the Georgia World Congress Center in Atlanta, Georgia. , Attendees ...
(Date:2/4/2016)... JUNCTION, N.J. , Feb. 4, 2016 /PRNewswire/ ... care immunotherapy leader commercializing its flagship CytoSorb® blood ... cardiac surgery patients around the world, announced that ... will present at the Source Capital Group,s 2016 ... and update on the company.  ...
Breaking Biology Technology:
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
Breaking Biology News(10 mins):